132 related articles for article (PubMed ID: 6157650)
21. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
[TBL] [Abstract][Full Text] [Related]
22. Current status of tumor markers in testicular cancer. A practical review.
Javadpour N
Eur Urol; 1992; 21 Suppl 1():34-6. PubMed ID: 1385131
[TBL] [Abstract][Full Text] [Related]
23. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Lange PH; Fraley EE
Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
[No Abstract] [Full Text] [Related]
24. Serum alpha fetoprotein and testicular tumors.
N Engl J Med; 1977 Mar; 296(12):693-4. PubMed ID: 65733
[No Abstract] [Full Text] [Related]
25. Tumor markers in germinal testis tumors.
Perrin P; Ardiet C; Pommatau E
Acta Urol Belg; 1985; 53(2):199-222. PubMed ID: 2409781
[No Abstract] [Full Text] [Related]
26. Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer.
Fossa SD; Mason M
Br J Urol; 1992 Jan; 69(1):108. PubMed ID: 1371085
[No Abstract] [Full Text] [Related]
27. [Human chorionic gonadotropin-like substance (hCGLS) in male patients with gastrointestinal cancer].
Ohyama Y
Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):20-8. PubMed ID: 2421150
[TBL] [Abstract][Full Text] [Related]
28. Serum neuron-specific enolase. A marker for responses to therapy in seminoma.
Kuzmits R; Schernthaner G; Krisch K
Cancer; 1987 Sep; 60(5):1017-21. PubMed ID: 2440552
[TBL] [Abstract][Full Text] [Related]
29. Tumor markers in testicular cancer--an update.
Javadpour N
Prog Clin Biol Res; 1985; 203():141-54. PubMed ID: 2421328
[No Abstract] [Full Text] [Related]
30. [Significance of alpha fetoprotein and human chorionic gonadotropin determination in malignant testicular tumors].
Cerný V; Fingerová H; Janousková M; Talas M
Rozhl Chir; 1978 Dec; 57(12):833-8. PubMed ID: 83681
[No Abstract] [Full Text] [Related]
31. [Monitoring clinical stages of testicular tumors using markers].
Base J
Rozhl Chir; 1989 Nov; 68(11):733-9. PubMed ID: 2483593
[TBL] [Abstract][Full Text] [Related]
32. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
[TBL] [Abstract][Full Text] [Related]
33. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
[No Abstract] [Full Text] [Related]
34. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
35. Serum markers in testicular tumors.
Narayana AS; Loening S; Weimar G; Culp DA
J Urol; 1979 Jan; 121(1):51-3. PubMed ID: 83396
[TBL] [Abstract][Full Text] [Related]
36. [AFP and hCG as tumor markers in therapy of malignant germ cell tumors].
Rjosk HK; Baltzer J; Gokel JM; Holzmann K; Mickan H; Schneider E
Arch Gynecol; 1979 Jul; 228(1-4):665-7. PubMed ID: 90486
[No Abstract] [Full Text] [Related]
37. [Lectin binding in immunohistologically AFP/HCG positive and negative testicular carcinoma].
Henke H; Balducci M; Dunzendorfer U
Urol Int; 1987; 42(1):53-7. PubMed ID: 2438837
[TBL] [Abstract][Full Text] [Related]
38. Testicular tumors.
Lightner DJ; Lange PH
Immunol Ser; 1990; 53():397-401. PubMed ID: 1713066
[No Abstract] [Full Text] [Related]
39. Treatment of seminoma: does a positive HCG influence prognosis?
Bartsch G; Mikuz G; Frommhold H; Scheiber K
Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
[No Abstract] [Full Text] [Related]
40. Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: conversion to negative with testosterone administration.
Catalona WJ; Vaitukaitis JL; Fair WR
J Urol; 1979 Jul; 122(1):126-8. PubMed ID: 88528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
